Recalls for Warfarin

Bioprosthetic Aortic Valves: FDA Notification - Reduced Leaflet Motion
10/05/2015 Medical Recall

FDA is working to design clinical studies to fully evaluate reduced valve leaflet motion. At this time, FDA believes that bioprosthetic aortic valves remain reasonably safe and effective when used according to their approved indications.

  • Category
    Warfarin